Correlation of preoperative combined positron emission tomography/computed tomograpy with surgical and histopathological findings for patients with endometrial cancer
Not Applicable
- Conditions
- Endometrial (Uterine) cancerCancer - Womb (Uterine or endometrial cancer)
- Registration Number
- ACTRN12609000402246
- Lead Sponsor
- Southern Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
All women presenting to Southern Health with diagnosis of endometrial cancer
Exclusion Criteria
Previous surgery for endometrial cancer
other cancers
Not for surgical intervention
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evidence of fluoro-2-deoxyglucose (FDG) uptake corresponding with presence of primary lesion<br>Will Use regression techniques to examine the influence of prognostic variables on test characteristics. For each of the tests calculate sensitivity, specificity, positive and negative values and compare the performance of the two tests with risk ratios and 95% confidence intervals[Following surgery and review of histopathology: Baseline only];Evidence of FDG uptake corresponding with presence of distant disease including lymphatic spread<br>Will Use regression techniques to examine the influence of prognostic variables on test characteristics. For each of the tests calculate sensitivity, specificity, positive and negative values and compare the performance of the two tests with risk ratios and 95% confidence intervals[Following surgery and review of histopathology: Baseline only]
- Secondary Outcome Measures
Name Time Method